Product Information

ERRIN 0.35 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.1026 per EA under NDC 75907007532. Its NADAC has been published 127 times since Jun 19, 2024.

FDA first approved this application on Oct 21, 2002. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERRIN 0.35 MG TABLET

NORETHINDRONE
$0.1026per EA

Strength

.35 mg/1

NDC

75907007532

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

NORETHINDRONE

Approval Type

Generic (ANDA)

FDA Application

ANDA076225

FDA Approved

10/21/2002

TE Code

AB2

On Market Since

3/10/2024

Pharmacological Classes

Progesterone Congeners
Progestin

Price Statistics

The NADAC for ERRIN 0.35 MG TABLET has been published 127 times since Jun 19, 2024, and over the history we have for it it has declined 2.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1026 per EA
All-time high$0.1082 (Sep 11, 2024)
All-time low$0.0691 (Nov 20, 2024)
52-week high$0.1026
52-week low$0.0849
Median price$0.0902
Average price$0.0904
Largest weekly change+43.4% (Aug 21, 2024)
Weeks tracked127
Tracking sinceJun 19, 2024

Price History

1W

+4.5%

1M

+11.0%

3M

+13.2%

6M

+8.8%

1Y

+17.7%

3Y

N/A

5Y

N/A

All

-2.1%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERRIN 0.35 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ERRIN 0.35 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.1026 per EA (NDC 75907007532), effective Nov 18, 2026.

How has the price of ERRIN 0.35 MG TABLET changed over time?

Over the history we have for it, the NADAC for ERRIN 0.35 MG TABLET has declined 2.1%. It has been tracked across 127 weekly CMS publications since Jun 19, 2024.

What are the highest and lowest recorded NADAC prices for ERRIN 0.35 MG TABLET?

Since Jun 19, 2024, the NADAC for ERRIN 0.35 MG TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.1082 (Sep 11, 2024), with a median of $0.0902 per EA.

Are there cheaper alternatives to ERRIN 0.35 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERRIN 0.35 MG TABLET, is $0.0906 per EA — about 12% below ERRIN 0.35 MG TABLET.

Who manufactures ERRIN 0.35 MG TABLET?

ERRIN 0.35 MG TABLET (NDC 75907007532) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.